VIKING GLOBAL INVESTORS LP

Average Profitability
12.87%
Insider Buys Quantity
16
Insider Buys Sum
$387.54M
Insider Sells Quantity
10
Insider Sells Sum
$600.37M

Insider Activity of VIKING GLOBAL INVESTORS LP

According to the SEC Form 4 filings, VIKING GLOBAL INVESTORS LP, being in a position of

  1. 10 percent owner at 4D Molecular Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 540000 shares for $10.55M,
    over all time since 2020-12-15, has bought 3050000 shares for $64.2M, and sold 540000 shares for $10.55M.

The largest purchase of all time was on 2019-06-27 and amounted to 9411800 shares of BridgeBio Pharma, Inc. for $160M.

The largest sale of all time was on 2024-01-02 and amounted to 6500000 shares of APi Group Corporation for $203.45M.

Biography of VIKING GLOBAL INVESTORS LP

No biography is available at this moment.

2024-06-17SaleAPi Group Corporation
APG
10 percent owner
39,032
0.0143%
$38.15$1.49M-7.74%
2024-03-05SaleAPi Group Corporation
APG
10 percent owner
3.04M
1.0979%
$34.25$104.07M-3.15%
2024-01-04Sale4D Molecular Therapeutics, Inc.
FDMT
10 percent owner
540,000
1.2278%
$19.53$10.55M-5.9%
2024-01-02SaleAPi Group Corporation
APG
10 percent owner
6.5M
2.6232%
$31.30$203.45M+10.31%
2023-08-28PurchaseInhibrx, Inc.
INBX
10 percent owner
511,627
1.13%
$19.35$9.9M+32.3%
2023-07-18SaleBridgeBio Pharma, Inc.
BBIO
10 percent owner
1.5M
1.0576%
$35.00$52.5M-10.82%
2023-06-22SaleRoivant Sciences Ltd.
ROIV
10 percent owner
13M
1.8097%
$9.90$128.7M+8.43%
2023-05-09Purchase4D Molecular Therapeutics, Inc.
FDMT
10 percent owner
850,000
2.3982%
$16.00$13.6M+4.5%
2022-01-11PurchaseAmylyx Pharmaceuticals, Inc.
AMLX
2.3M
11.5074%
$19.00$43.7M+23.75%
2021-09-17PurchasePROCEPT BioRobotics Corporation
PRCT
10 percent owner
400,000
3.0225%
$35.00$14M-10.97%
2021-09-03SaleFIGS, Inc.
FIGS
10 percent owner
84,826
0.0531%
$44.92$3.81M-54.58%
2021-09-02SaleFIGS, Inc.
FIGS
10 percent owner
315,174
0.2036%
$47.28$14.9M-55.36%
2021-07-29PurchaseRallybio Corporation
RLYB
10 percent owner
806,000
2.6995%
$13.00$10.48M-22.23%
2020-12-15Purchase4D Molecular Therapeutics, Inc.
FDMT
10 percent owner
2.2M
4.7935%
$23.00$50.6M-22.23%
2020-12-14SaleAdaptive Biotechnologies Corporation
ADPT
10 percent owner
1M
6.3483%
$55.65$55.65M-33.77%
2020-12-01SaleZentalis Pharmaceuticals, Inc.
ZNTL
10 percent owner
500,000
1.7356%
$50.50$25.25M+2.62%
2020-08-26PurchaseInhibrx, Inc.
INBX
10 percent owner
180,219
0.6943%
$18.92$3.41M+32.73%
2020-08-25PurchaseInhibrx, Inc.
INBX
10 percent owner
85,304
0.3175%
$19.36$1.65M+25.01%
2020-08-24PurchaseInhibrx, Inc.
INBX
10 percent owner
46,161
0.1645%
$19.43$897,001+19.04%
2020-04-07PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
10 percent owner
1.45M
3.199%
$18.00$26.1M+70.78%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.